Telo Genomics Company Insiders
| TELO Stock | CAD 0.11 0.01 8.33% |
Telo Genomics employs about 3 people. The company is managed by 3 executives with a total tenure of roughly 6 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Recap of Telo Genomics' management performance can provide insight into the venture performance.
Telo |
Telo Genomics Management Team Effectiveness
The company has return on total asset (ROA) of (0.8732) % which means that it has lost $0.8732 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.6942) %, meaning that it generated substantial loss on money invested by shareholders. Telo Genomics' management efficiency ratios could be used to measure how well Telo Genomics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to climb to -0.12 in 2024. Return On Capital Employed is likely to climb to -0.13 in 2024. At this time, Telo Genomics' Total Assets are fairly stable compared to the past year. Total Current Assets is likely to climb to about 3.4 M in 2024, whereas Intangible Assets are likely to drop slightly above 520.3 K in 2024.Common Stock Shares Outstanding is likely to climb to about 72.6 M in 2024, whereas Net Loss is likely to drop (2.5 M) in 2024.
Telo Genomics Workforce Comparison
Telo Genomics Corp is currently under evaluation in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 32.0. Telo Genomics adds roughly 0.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Telo Genomics Corp Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Telo Genomics Corp Price Series Summation is a cross summation of Telo Genomics price series and its benchmark/peer.
Telo Genomics Notable Stakeholders
A Telo Genomics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Telo Genomics often face trade-offs trying to please all of them. Telo Genomics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Telo Genomics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Sabine Mai | Interim Founder | Profile | |
| CGA CPA | Chief Officer | Profile |
About Telo Genomics Management Performance
The success or failure of an entity such as Telo Genomics Corp often depends on how effective the management is. Telo Genomics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Telo management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Telo management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (2.86) | (0.12) | |
| Return On Capital Employed | (4.61) | (0.13) | |
| Return On Assets | (2.81) | (0.12) | |
| Return On Equity | (4.60) | (0.12) |
Please note, the imprecision that can be found in Telo Genomics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Telo Genomics Corp. Check Telo Genomics' Beneish M Score to see the likelihood of Telo Genomics' management manipulating its earnings.
Telo Genomics Workforce Analysis
Traditionally, organizations such as Telo Genomics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Telo Genomics within its industry.Telo Genomics Manpower Efficiency
Return on Telo Genomics Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 940.3K | |
| Net Loss Per Executive | 940.3K | |
| Working Capital Per Employee | 854.2K | |
| Working Capital Per Executive | 854.2K |
Additional Tools for Telo Stock Analysis
When running Telo Genomics' price analysis, check to measure Telo Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telo Genomics is operating at the current time. Most of Telo Genomics' value examination focuses on studying past and present price action to predict the probability of Telo Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telo Genomics' price. Additionally, you may evaluate how the addition of Telo Genomics to your portfolios can decrease your overall portfolio volatility.